Periprocedural cilostazol treatment and restenosis after carotid artery stenting: The retrospective study of in-stent restenosis after carotid artery stenting (ReSISteR-CAS)

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 3, 2012, Pages 193-199

  Yamagami, Hiroshi ^a   Sakai, Nobuyuki ^a   Matsumaru, Yuji ^b   Sakai, Chiaki ^c   Kai, Yutaka ^d   Sugiu, Kenji ^e   Fujinaka, Toshiyuki ^f   Matsumoto, Yasushi ^g   Miyachi, Shigeru ^h   Yoshimura, Shinichi ⁱ   Hyogo, Toshio ^j   Kuwayama, Naoya ^k   Hyodo, Akio ^l  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b TORANOMON HOSPITAL   (Japan)

^c INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^d UNIVERSITY OF THE RYUKYUS   (Japan)

^e OKAYAMA UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Konan Hospital   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ GIFU UNIVERSITY   (Japan)

^j Nakamura Memorial Hospital   (Japan)

^k UNIVERSITY OF TOYAMA   (Japan)

^l DOKKYO MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

antiplatelet therapy; carotid artery stenosis; Endovascular therapy

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; DEATH; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; THROMBOEMBOLISM;

AGED; CAROTID STENOSIS; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; STENTS; TETRAZOLES;

EID: 84858789489     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2010.06.007     Document Type: Article

References (30)

1. H.J. Barnett, D.W. Taylor, and M. Eliasziw North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis N Engl J Med 339 1998 1415 1425 (Pubitemid 28516064)
2. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST) Lancet 351 1998 1379 1387
3. A. Halliday, A. Mansfield, and J. Marro Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial Lancet 363 2004 1491 1502
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study Endarterectomy for asymptomatic carotid artery stenosis JAMA 273 1995 1421 1428
5. J.S. Yadav, M.H. Wholey, and R.E. Kuntz Protected carotid-artery stenting versus endarterectomy in high-risk patients N Engl J Med 351 2004 1493 1501
6. J.L. Mas, G. Chatellier, and B. Beyssen Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis N Engl J Med 355 2006 1660 1671 (Pubitemid 44583956)
7. P.A. Ringleb, J. Allenberg, and H. Bruckmann 30-day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial Lancet 368 2006 1239 1247
8. K. Groschel, A. Riecker, and J.B. Schulz Systematic review of early recurrent stenosis after carotid angioplasty and stenting Stroke 36 2005 367 373 (Pubitemid 40170824)
9. M.A. Khan, M.W. Liu, and F.L. Chio Predictors of restenosis after successful carotid artery stenting Am J Cardiol 92 2003 895 897 (Pubitemid 37163598)
10. Z. Zhang, J.K. Foster, and P. Kolm Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: Results from the Cilostazol for RESTenosis (CREST) trial Am Heart J 152 2006 770 776 (Pubitemid 44396877)
11. U. Tamhane, P. Meier, and S. Chetcuti Efficacy of cilostazol in reducing restenosis in patients undergoing contemporary stent-based PCI: A meta-analysis of randomised controlled trials EuroIntervention 5 2009 384 393
12. G.G. Biondi-Zoccai, M. Lotrionte, and M. Anselmino Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention Am Heart J 155 2008 1081 1089
13. O. Iida, S. Nanto, and M. Uematsu Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions J Vasc Surg 48 2008 144 149
14. Y. Soga, H. Yokoi, and T. Kawasaki Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication J Am Coll Cardiol 53 2009 48 53
15. T. Takigawa, Y. Matsumaru, and M. Hayakawa Cilostazol reduces restenosis after carotid artery stenting J Vasc Surg 51 2010 51 56
16. Joint Committee of the Japan Academy of Neurosonology and the Japan Society of Embolus Detection and Treatment on Guideline for Nuerosonology. Carotid ultrasound examination Neurosonology 19 2006 49 69 (in Japanese)
17. T.J. Wang, B.H. Nam, and P.W. Wilson Association of C-reactive protein with carotid atherosclerosis in men and women: The Framingham Heart Study Arterioscler Thromb Vasc Biol 22 2002 1662 1667
18. H.S. Gurm, J.S. Yadav, and P. Fayad Long-term results of carotid stenting versus endarterectomy in high-risk patients N Engl J Med 358 2008 1572 1579 (Pubitemid 351519817)
19. L.H. Bonati, J. Ederle, and D.J. McCabe Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): Long-term follow-up of a randomised trial Lancet Neurol 8 2009 908 917
20. H.H. Eckstein, P. Ringleb, and J.R. Allenberg Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: A multinational, prospective, randomised trial Lancet Neurol 7 2008 893 902
21. C. Setacci, E. Chisci, and F. Setacci Grading carotid intrastent restenosis: A 6-year follow-up study Stroke 39 2008 1189 1196 (Pubitemid 351440690)
22. A.F. AbuRahma, S. Abu-Halimah, and J. Bensenhaver Optimal carotid duplex velocity criteria for defining the severity of carotid in-stent restenosis J Vasc Surg 48 2008 589 594
23. G.A. Younis, K. Gupta, and A. Mortazavi Predictors of carotid stent restenosis Catheter Cardiovasc Interv 69 2007 673 682 (Pubitemid 46581255)
24. A. Willfort-Ehringer, R. Ahmadi, and A. Gessl Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state Diabetologia 47 2004 400 406 (Pubitemid 38491235)
25. M. Schillinger, M. Exner, and W. Mlekusch Acute-phase response after stent implantation in the carotid artery: Association with 6-month in-stent restenosis Radiology 227 2003 516 521 (Pubitemid 36514771)
26. R. Topakian, M. Sonnberger, and K. Nussbaumer Postprocedural high-density lipoprotein cholesterol predicts carotid stent patency at 1 year Eur J Neurol 15 2008 179 184
27. K. Tanaka, F. Gotoh, and Y. Fukuuchi Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia Stroke 20 1989 668 673 (Pubitemid 19139099)
28. S. Goto Cilostazol: Potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding Atheroscler Suppl 6 2005 3 11 (Pubitemid 43263084)
29. S.D. Rybalkin, I. Rybalkina, and J.A. Beavo Cyclic nucleotide phosphodiesterase 1C promotes human arterial smooth muscle cell proliferation Circ Res 90 2002 151 157 (Pubitemid 34627083)
30. O. Iida, S. Nanto, and M. Uematsu Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery Circ J 69 2005 1256 1259 (Pubitemid 41382949)